Myalepta (metreleptin)

pCPA File Number: 22611
Negotiation Status:
Active Negotiation
Indication(s):
Leptin deficiency in lipodystrophy
Sponsor/Manufacturer:
Medison Pharma Canada Inc.
CDA-AMC Project Number:
SR0784-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable